Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
First of all I want to apologize. We missed it today. Looked real good for a while at the $4.50 mark but a second wave hit not just CYDY but the entire market was in a sell off. Good majority of Covid plays down. Top it off with the GSK news, that added a little downward pressure. Today was in gambling called a bad beat. Don’t get discouraged as this is the way it is in the wild Wild West of OTC. It seems like a puppet the strings get pulled by shirts and MM as CYDY becomes the good ole standby to short. But big difference is we will get the last laugh very soon. Who knows maybe even a surprise PR for an uplist. Enough to put the fear of ... into the shirts. Misiu great explanation in Cancer with Pestell
Look at t ty he game played by MM right now at $4.50 exactly where we called a buy. This is turning point upward. They cannot hold that line
Could be a nice big number but I like to start out small as we are a small biotech. I do not like putting out those projections. Others are much better at that than I am. Short term everyone knows the stock is volatile especially on OTC market, but if you believe in the science, the many doctors who know the drug works, the papers written, the EINDs you hang on even with those pesky shorts who lie and distort. The share price from here looks steady as we await what will be next. We are expecting positive news in a few weeks time. EUA in itself is nice but full approval is better of course. We are somewhere in the middle. Baby steps. Especially that we have been in this position before and have seen firsthand missteps along the way to a sure thing. Look for battle lines to form again around $5. Just remember a Green Day regardless of how big or small is better than no gain.
Looking ahead to tomorrow’s trading as we trend higher. Today’s close held up very well. We were expecting some profit takers and day traders to shave a little more off the top into close. Shorts may make a feeble attempt at start of trading day to nudge price lower, but we feel that each attempt will be weak as any dip will be bought up quickly. Same as today a lull into midday then a nice trend line and gap up. We may touch $5 and retrace down a step but on the buy side $4.50 for a low equals buy and close at or above $4.85 equals forward momentum.
Nice post. Agree with what you presented and want to see the best TLD to refute all the naysayers that we are a fraud and a saline shot. We need to have something in place to alleviate the deaths and give those who get infected hope of being able to pull through. I think most don’t believe that Virologix is sub Q which in itself is mind blowing, and to get the positive news from trials, papers published and prove that what we have works will be the icing on the cake. Two weeks is better than nothing but it is still too long for those that need Virologix now.
I agree but the million dollar question is??? Guess vaccines. As soon as variants and mutations were announced vaccine companies were on it with booster shots. Also stating that the vaccines are effective against the strains. I say bull turd. They do not want any competition. Period. This is why we need to prove that we are different in the MOA. I look at it this way. Knowing DSMC recommending 75% and 42 days, they were on to something. To see if twanging the days in mortality, that they would be able to possibly cut trial short and make recommendations for efficacy hitting endpoint. But being that we went and had huge enrollment so quickly NP said we are gonna go with completed trial results. Now new guidance by FDA is stretching it out to 60 days. Why? Bcuz they see many who are released from treatment by SOC end up returning to hospital shortly thereafter and in worse shape with mortality. Maybe as much as 10% get readmitted. That is why you do not disregard recommendations, however trivial they may seem. Let’s hope the stretched out parameters will be used if need be to get us Stat Sig. We feel very strong about secondary endpoints being achieved at Stat Sig in many secondary endpoints, and that is why they are in discussions with all the agencies. Questions being thrown out there for dosing, usage, labeling, manufacturing, sharing inventory. To be unified and that is why things are confidential. Because it is phase 3, hitting primary will not matter. As long as in the FDAs own verbiage the drug is safe which we know already and more effective than what is currently available, which is nothing for S/C so far. My theory is like a dartboard. We still may have hit primary mortality at 28 day but it may be like hitting center cork. At 42 day maybe it was like hitting outer cork. And now at 60 days it would be like hitting a number. With secondary endpoints, it’s just hitting the board that matters and designing usage for those endpoints is what’s in discussions now. I am optimistic still that we could hit primary endpoints but IMO as others have stated if we did it would be put out there IN BOLD HEADLINES
There is a dilemma ahead as we hear of J&J vaccine coming on board. Govt is racing for herd immunity and pushing out vaccines at rapid scale. We know that they are looking to achieve this by June which coincides with warm weather, outdoor activities and the fact that the virus slows in the summer. Right now vaccines show good efficacy but you can still contract the virus. Supposedly the affects are lessened due to body producing antibodies. This takes away some firepower for S/C need. It won’t eliminate it totally as many people have comorbidities.
What we do see is approval for S/C hopefully for primary endpoints, but a lock for secondary endpoints which gives us a key to unlock the door. And this is where we line up the ducks. LONGHAULERS will be the most consequential development for Virologix. This in our opinion will be the biggest game changer ever. With all of the major data collected during quick 100 person trial, we will have ample exposure and when data is verified and the trial is complete and successful, the amount of product we will need will never end.
Revenues will flow allowing us to conduct multiple trials for all the indications OHM has listed and I believe last count was 63.
Hit the sweet spot as called $4.75 and held onto most gains. Very good support at end of day as the fade down was not impressive. Next leg up for tomorrow is $4.85. If we can hold that level it is the next sweet spot. I know we got hit with a coordinated hit piece on Sunday night, then an early morning Twitter by AF and the subsequent PR which was positive but once again giving a timeline left a long runway for shirts. Enough time to hit hard cause a huge drop and book of profits and then a retreat. Medium volume day but much lower that Monday and Tuesday as the weak hands, newbies, and those who made the mistake of stop loss orders crashed the share price. Those who hold will get payback. We still feel strongly on secondary endpoints which we feel were positive and with new recommendations from FDA and during trial DSMC, we shall know shortly TLD. Our odds on success and EUA are topping 90% but things are still being looked at. There was no breakout today, just a recovery of an oversold stock. I stand by my predictions and still hold firm to what was previously posted, with slight delay due to short attack. Stay the course.
Much talk has been about the recent statement put out by FDA regarding timeframes to 60 days. Hence this is where the DSMC recommendation of 75% at 42 days starts to make sense. Mortality at 28 day with the improved standard of care most likely wasn’t helping us to achieve Stat Sig in our trial the way it was 2-1. But seeing that once the SOC patients went past 28 days and started to deteriorate due to the fact the virus became immunological, the patients deteriorated quickly and probably succumbed to the virus. Fact is many who are discharged like 10% end up back in hospital because after release they deteriorate if not fully cleared of virus. Some do not regress that far to mortality, hence they become Longhaulers. The recommendations by the DSMC and now new guidelines from the FDA bring light to why Leronlimab is needed and as DR Patterson alluded to . Once the virus passes a certain stage it becomes immunologic which CYDY assists the body to reduce the cytokine storm and viral load. The information being gathered now after completion of trial has extended out beyond those timeframes but being that trial was filled so we know if these new parameters are being discussed as inclusion for our trial to meet Stat Sig.
Wow. Look at what happens when you get an honest take on a PR. Also notice that the volume is around half of what it was the past two days. Can you say after the hit piece on a Sunday night at 9:38 pm before NPs PR at 3am was not a coordinated short strike for Monday mornings open. 3 million shares less traded today and an up day. Price is at a good point for continued gains rest of week. Next level to break is $4.75-4.80 which may come later today with a second wave push in the afternoon before settling back to a healthy $4.60 with some day trading profit takers. But those that do not believe, heed the warning that this is the next generational stock. The new penicillin moving forward. Janet Woodcock will be named Head Of FDA after announcement no more interim status. Virus? What virus? Pandemic? What pandemic? Virologix approval will take care of it.
Here is something to chew on. Every Medicaid code so far that has been issued has been given approval. We are the next one and only one with game changing subQ injection. Longhaulers is ready to start and if you think an approval for CD-12 is good, just wait til we get approval for Longhaulers. The potential in Longhaulers sets the bar for us. As Dr Patterson said Virologix needs to be stockpiled for future pandemics as we know we have a drug that quiets the cytokine storm, reduces viral load 3 days and restores homeostasis so the body can fight off the disease naturally. One approval and I see $3-5 billion in revenues in 6-12 months and close to $15-20 in 2 years.
Competition is good. It makes all drugs compete to be the best and offers us hope. As long as the playing field is level, who cares who wins. Right now there is a need to eradicate this terrible virus. I’m sure that everyone enjoys wearing a mask (the latest two) and to remain six feet away from another human being and wash hands until skin falls off. Yeah right. We need to fight worldwide. This is not a local virus. The more successful we are at stopping Covid the quicker we can get back to life. Hope lies with the FDA to do the right thing bcuz with the other agencies in discussions with CYDY the games and fraud are over.
Zuess let’s face it. Fauci and the FDA have been late to the Leronlimab party for practically a year now. When you do all the talking and no listening you only hear yourself and that is very bad. These best of the best are frauds who only back their buddies BP. The nepotism and cronyism is so obvious to most Americans. Think of all the drugs that have been approved and follow the $. It is such a joke. And then think of how insane it is that some on This board would go to great lengths to wish failure during a pandemic to save lives. Something is gonna give in a big way and once this beast Virologix is released, the investigation into the corrupted Fauci and FDA should begin with an unbiased unappointed connection. The truth needs to be known how $ and BP crush whoever stands in their way.
I can’t bear listening to Fauci. Anything to do with BP or Big Govt is a slap in CYDY face. As a pre revenue bio, we do not have much bark let alone bite to say or do anything to ruffle any feathers. We are puppets and yes men to whatever whims or flavor of the day that comes to mind. Now that not only does FDA but also many others have this data, there is less room for any manipulation. It would get exposed. Any bias is not from only one agency. This is very prudent and smart. Everything we have done recently has included MHRA and Canada and whoever else. Why? Because we know it puts pressure on the FDA. That is why IMHO there are ongoing discussions with all because we need leverage. Too many times the paper has been thrown back at us as incomplete of given an F in red marker. That is why Mahoob is here. That is why we have a scientific research department with very smart people. To stop the FDA from railroading us. Times are changing. Just as the season is and trust now is challenged. I think NP finally sees the light at the end of the tunnel. Don’t be alarmed at current share price. One day in the next week you are gonna wake up and be mightily surprised.
Debating if I should set stop loss orders for $3 or $2.50.JK.but apparently others must have set them down to $4. Let’s watch where we pull a rabbit out of a hat. All news is good unless you are a shirt. Then anything said or PRd is bad.
Convergence is at $4. The Mason-Dixon Line. Seems that last PR has given shirts a runway to time out their final hits before the well runs dry. Having played themself into a corner, the bull run is about to start. By tomorrow afternoon there is a 72% chance that we move rapidly higher throughout the day. Fear not what lies ahead, only embrace what is about to happen. We will end up 20-23% higher than the lows of the week. Looking at $4.80- low side and $5.95 high side.
I have relayed and parlayed all relative information to contacts well established in medical field from major hospitals and my contacts formerly with BP and with this information, they have given me major assurances that the PR and path forward with FDA is about secondary endpoints that are being looked at. The probability is extremely high that discussion are related to EUA being granted for the secondary endpoints being hit and the format to which Virologix will be used to treat either Severe or Critical patients.
Misiu we have been played by many each time we think we have news locked up, we get held up or FDA finds something not to their liking. I’m with you as I am riding very strong on EUA but for secondary endpoints. Stat Sig would be great for mortality but as we see now as vaccines become more prevalent and touted as the savior, the need for S/C will be lessened. Mortality rates have come down recently and all the rage is which next vaccine will stop Covid in its tracks. Booster shots, variant killing vaccines all touted by Fauci and BP becuz they don’t want anything to get close to their punch bowl. But more precision therapeutics that target CCR5 and block Covid and have positive outcome for specific endpoints will get us EUA.
Looks like more of the same tomorrow with heavy push down at start of day likely to $4 before minor buying and then continue spiral where shorts try to bring this down to $3.60. Spin all week wash rinse @ repeat. Will buyers step in enough to be able to offset the fire sale? Or will shorts and MM dictate how low they want this stock to go. Somewhere between the lies and deceit is the truth. How many longs have the stomach and guts to fight back and buy on the massive dips. Two weeks is a lot of time if NP is telling it straight. But if it is actually one week all the shirts gains may get squeezed and really hard.
Typical buy the rumor and sell the news. Listen this was all set up last night with SA article. It was definitely a tip off to sell hard and early. Unfortunately the timing of the PR which although very positive was twisted into a pretzel failure by not giving top line results. If you are a long you know that the FDA requested raw data as soon as trial was unblinded, which is exactly what CyDY did. OLE and EINDS continued and now All three agencies are in discussions regarding this. How is this bad? Shorts that’s how. Every time NP speaks, it is a hit job. Take it with a grain of salt. These weak attempts show success by creating fear and doubt. Why would you sell when you know what you have in your hand. A GOLDEN TICKET -LOTTO. I know what I have researched and the team I have has done major DD. We are on the Cusp of an approval
Glad that the shirts made lots of money today scaring weak hands and newbies. Flush them out cuz this is a big boys stock. When our time comes soon, it will be bittersweet to see the same who gloat today to be crying I. Their beer if they can afford one
We know we have to wait for FDA and it may be 2-3 weeks for what’s waiting for us next. This was a perfect moment for an attack which was precluded by FUD SA article late yesterday. Was a signal to shorts to hit stock heavy and spread misinformation of course that trial failed. Every single one of my sources tell me this is statistically a lock that there is endpoints that will be used to give us an EUA on that endpoint wether it is Primary or secondary. We have rehashed all the timelines and so far every one is in line with their forecast. Only problem we have is NP who has no clue of this and opens us up to short attacks. But besides him, we are poised to get what we needed from the results, an EUA most likely by week of 3/10
Virologix can be approved and the shirts would still talk about NP rap sheet from 30 years ago. All the ammo and weapons don’t mean nothing if you can’t shoot straight. Fear will come back a thousand times against what they try and create. Medicaid codes will be used very soon after approvals and the dam will burst wide open. A flood of good news awaits.
Didn’t the FDA request that they wanted unblinded data before CYdY divulged any results publicly? Isn’t that exactly what they did as requested by the FDA? All the other short FUD is directed at falsifying what CYDy did which is follow the FDA guidelines. And with no stoppage in EINDs or halt to Virologix what does this spell out? I have spoken to my contacts and we have concluded that the fear created by shirts is unwarranted. Best case scenario is we hit primary endpoints in mortality. Second best outcome is we hit secondary endpoints where in the FDAs own words if in time of this pandemic we have a therapeutic which is safe and shows efficacy to which no one else has shown then frug will be approved. Since we have seen amazing results in EINDs and know that Virologix provides a benefit we will be approved. Secondary endpoints will be granted EUA.
Nader news always puts us down 6-8% regardless of what it is. Shirts spin it in their favor and collapse share price at start of day only to have to cover by end of day. Why not load up on the gifts they bring. This will have major traction by end of week. Shorts know they will have to close out position but with announcement of 2 weeks after unblinding, this gives them time frame of how long they have to get out before approval
Let’s face it. Any news short of top line results and approval would get twisted by shorts as failure. We have all been through this game before. When this hits $4.50 there is a huge buying opportunity as the rise will be meteoric. Analysis still has us hitting $6.69 by end of week. Load up as shirts will create FUD all week in attempts to exit position.
I’m getting unverified news that NP will crack his knuckles in the next video. Firing up the ouija board to make sense of all of this. Could this possibly be the news2 we were looking for? Have a Great Weekend Longs. Soon very soon.
Or it could be NP was flashing signs picked up from his stint back in the big house in 86 for bouncing a hundred dollar check, but I’ll stick with the first one. The second one is for the shirt conspiracy theory that and the foreign outlet.
Decoding NP last video this is what was said. When he held up his 3 fingers it wasn’t to let us know stock was triple digit yet more to let us know that it represents (3) for March and one hundred dollar stock is (1) meaning the first. So it would appear to be that he gave us the green light to buy all this week because we will be releasing results on Monday March 1st. That is why we saw the big grin. Also a dead giveaway was the outlet behind him. IMHO of course. Enjoy the quiet weekend longs. Back to work and Ouija board checking on next weeks outcomes.
Seeing nice hodl line forming. Rally into weekend close. Closer to trial results and start of Longhaulers trial. One question Do you really think that CYDY and Mahoob are not advancing what’s needed to resubmit BLA for HIV ? I don’t . This may be a lot closer to being realized than what most think.
No news tomorrow and I hope I’m wrong but we may be red. Only 4 days this week got a reprieve market was closed on Monday. 3 shots $5.25 if we don’t hold there $5.10 and if the floor falls out $4.88. Let’s hope for a bounce instead and salvage $5.55 going into weekend.
This is wrong. Longs not selling Fact1. Shorts taking advantage of quiet period. Fact 2 big mistake on their part. Share price is going to settle where the bargain price becomes overplayed. Just a matter of time. A few newbies and those who got in late hoping for trial results to be announced quickly likely have jumped ship. On this volume, there is a ton of rinse and repeat trades mostly by shirts just moving price around while trying to instill the theory of no news and delays equal bad news. Fact 3 WRONG
Seeing how long it’s taking for J&J vaccine to get to where it needs to go with meeting on 2/26 I’m guessing meeting occurs with FDA on 3/26 with approval to follow. Seems to make sense with timeline set for J&J. If you read post from Hulks timeline could be data lock on 3/1 with 1 week to unblind which would put top line trial results around 3/10 and meeting with FDA approximately 2 weeks later. After review approval by 4/1 kind of what it said for trial completion. Maybe that’s why they said April to begin with. Not sure
Excellent presentation for timeline. After giving CD-10 piecemeal and hearing nothing but fallout, it is smart to remain silent until data locked and unblinding released. Let shirts rehash all the boring material they throw at us. Knowing that data is still being scrubbed and entered meticulously is far more important than racing to the finish line with mistakes being made. Only get one chance at making a first impression so let’s give it our best. As far as share price goes we bounced off of $5.25 last time and shot straight up. If we go below that support and buying will be supported at $5.10. Not sure if shorts have that much courage or water in their pistols. Resistance can start at $5.85. It if we break out $6 is next stop, although IMO we are heading in a higher direction.
Check out how many google hits there will be on CYDY /Leronlimab/Longhaulers/ Virologix. My uneducated guess is it will be one of the top trending subjects and searches. I like playing pool. And what I was always taught was play position to set up your next shot and if you could ty make it, make sure you didn’t leave your opponent an opportunity to make one. Well here is that setup and why we are very comfortable with our DD and analysis. The angles and strategy involved in strategic planning will never get old.
Think about the video of the guy driving feomNY to Florida’ to get into this trial. How many others will be begging to get into this? I can almost guarantee the amount of media attention we get will triple by Friday, and as our favorite poster Monroe always says I love the weekends. One more as Black Ops would say Sleep Tight Shorts
I’m gonna tickle some chords on the ivory. Think about this right now for tmorrow and why we feel like we break out. We haven’t heard one thing about results from CD-12. But so far today, there have been multiple reports and you tube videos announcing Longhaulers trials in Florida and now UCLA story just put out. Do not think for one second the amount of traction this is going to bring and the amount of publicity this is going to get and couple that with the fact we are just moments away from terrific results of CD-12 to become the new savior. That is why in our humble opinion the discount window will shut quickly, probably after a minor short attempt at the start of day and then once media starts running with longhaulers the floodgates will open. Once we cross that resistance at $6 that MM have been teasing us with, we are taking out $6.25 and sailing to our target. Godspeed
Wow four years is a lot of time to be invested and throw in the towel, but I understand your frustrations. This is the absolute crossroads for shareholders. Some are all in regardless of loss it seems, and others just are tired of the games. Best of luck to you whichever road you choose. Always fair and balanced in your posts. I have heard you praise and I have heard you bash. Middle ground and a strong stomach to be in this long
Amazing. How little acknowledgment amongst the most knowledgeable including the most obvious Dr A.F world renown NIH director. Rock thanks for enlightening me on all these articles and Latane a shout out. You would think by now the medical world would have some kind of idea of CYDy. How long can they be kept in the dark? What will it take for the world to take notice? Can’t wait to see the expression on their faces?
Not sure if this rumor is true but I’m hearing 2 shots of Leronlimab saline solution is saving peoples lives and also helping with longhaulers. Think we may have something here. Long and strong. Slow and steady as the tortoise would say wins the race. Vaccines will not be effective against all mutations. Therapeutics will come to the rescue. Not gonna put any numbers on rest of week. Seems like the accuracy has been pretty good and not sure if it is helping anyone but shorts.